Artificial ribonucleases:: Efficient and specific in vitro cleavage of human c-raf-1 RNA

被引:31
作者
Canaple, L
Hüsken, D
Hall, J
Häner, R
机构
[1] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland
[2] Novartis Pharma AG, Funct Genom, Basel, Switzerland
关键词
D O I
10.1021/bc0200024
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We report here the first successful sequence-specific cleavage of large RNA using artificial ribonucleases. A series of uniformly 2'-methoxyethoxy-modified oligonucleotides bearing a europium complex were investigated as artificial ribonucleases specific for the human c-raf-1 mRNA. The efficiency and specificity of these oligonucleotide-metal conjugates to bind and to cleave 571 and 2977 nucleotides long c-raf-1 RNA transcripts in vitro in a sequence-specific manner is demonstrated. Quantitative analysis reveals a cleavage efficiency of 60-70% within 4 h at 37degreesC. Precise mapping of cleavage sites using primer extension analysis shows that cleavage generally occurs at two or three major sites adjacent to the 3'-end of the RNA target region. Cleavage is preferentially observed after purine nucleotides. This study demonstrates the potency of artificial ribonucleases targeting large, biologically relevant RNAs.
引用
收藏
页码:945 / 951
页数:7
相关论文
共 27 条
[1]   Antisense therapeutics [J].
Agrawal, S ;
Zhao, QY .
CURRENT OPINION IN CHEMICAL BIOLOGY, 1998, 2 (04) :519-528
[2]   Oligonucleotide-europium complex conjugate designed to cleave the 5′ cap structure of the ICAM-1 transcript potentiates antisense activity in cells [J].
Baker, BF ;
Lot, SS ;
Kringel, J ;
Cheng-Flournoy, S ;
Villiet, P ;
Sasmor, HM ;
Siwkowski, AM ;
Chappell, LL ;
Morrow, JR .
NUCLEIC ACIDS RESEARCH, 1999, 27 (06) :1547-1551
[3]   Discovery and analysis of antisense oligonucleotide activity in cell culture [J].
Baker, BF ;
Condon, TP ;
Koller, E ;
McKay, RA ;
Siwkowski, AM ;
Vickers, TA ;
Monia, BP .
METHODS, 2001, 23 (02) :191-198
[4]  
BOS JL, 1989, CANCER RES, V49, P4682
[5]   Antisense oligonucleotide inhibition of serine threonine kinases: An innovative approach to cancer treatment [J].
Cho-Chung, YS .
PHARMACOLOGY & THERAPEUTICS, 1999, 82 (2-3) :437-449
[6]   Molecular mechanisms of action of antisense drugs [J].
Crooke, ST .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1999, 1489 (01) :31-44
[7]  
Geary RS, 2001, J PHARMACOL EXP THER, V296, P890
[8]  
Geary RS, 2001, J PHARMACOL EXP THER, V296, P898
[9]   Isotype-specific functions of Raf kinases [J].
Hagemann, C ;
Rapp, UR .
EXPERIMENTAL CELL RESEARCH, 1999, 253 (01) :34-46
[10]   Towards artificial ribonucleases: The sequence-specific cleavage of RNA in a duplex [J].
Hall, J ;
Husken, D ;
Haner, R .
NUCLEIC ACIDS RESEARCH, 1996, 24 (18) :3522-3526